Evidence map›Paper›PMID 33498474›Full record

ArticleCells2021

LRRK2 Modulates the Exocyst Complex Assembly by Interacting with Sec8.

Milena Fais, Giovanna Sanna, Manuela Galioto, Thi Thanh Duyen Nguyen, Mai Uyên Thi Trần, Paola Sini, Franco Carta, Franco Turrini, Yulan Xiong, Ted M Dawson and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Inhibition of the Exocyst Complex Attenuates the LRRK2 Pathological Effects.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Milena FaisDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
Giovanna SannaDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
Manuela GaliotoDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
Thi Thanh Duyen NguyenDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0002-5005-7625
Mai Uyên Thi TrầnDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0003-1870-4439
Paola SiniDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
Franco CartaNurex srl, 07100 Sassari, Italy.
Franco TurriniNurex srl, 07100 Sassari, Italy.
Yulan XiongNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Ted M DawsonNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.ORCID 0000-0002-6459-0893
Valina L DawsonNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Claudia CrosioDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
Ciro IaccarinoDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0003-1619-7146
University of Sassari · ITJohns Hopkins University · USUniversity of Turin · IT

Funding

Fondazione Banco di Sardegna 2014.0489Michael J. Fox Foundation for Parkinson's Research LRRK2 Challenge 2014 ID9550Ministero dell'Istruzione, dell'Università e della Ricerca PON 2014-2020 (CCI2014IT16M2OP005)NIH HHS P50 NS38377Regione Sardegna CRP-78083
6 · The paper itself

Abstract

Mutations in LRRK2 play a critical role in both familial and sporadic Parkinson's disease (PD). Up to date, the role of LRRK2 in PD onset and progression remains largely unknown. However, experimental evidence highlights a critical role of LRRK2 in the control of vesicle trafficking, likely by Rab phosphorylation, that in turn may regulate different aspects of neuronal physiology. Here we show that LRRK2 interacts with Sec8, one of eight subunits of the exocyst complex. The exocyst complex is an evolutionarily conserved multisubunit protein complex mainly involved in tethering secretory vesicles to the plasma membrane and implicated in the regulation of multiple biological processes modulated by vesicle trafficking. Interestingly, Rabs and exocyst complex belong to the same protein network. Our experimental evidence indicates that LRRK2 kinase activity or the presence of the LRRK2 kinase domain regulate the assembly of exocyst subunits and that the over-expression of Sec8 significantly rescues the LRRK2 G2019S mutant pathological effect. Our findings strongly suggest an interesting molecular mechanism by which LRRK2 could modulate vesicle trafficking and may have important implications to decode the complex role that LRRK2 plays in neuronal physiology.

Indexed as

AnimalsCell Line, TumorHEK293 CellsHumansLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Membrane ProteinsMiceMice, KnockoutMultiprotein ComplexesPC12 CellsProtein BindingRatsVesicular Transport ProteinsEXOC4 protein, humanExoc4 protein, ratLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Membrane ProteinsMultiprotein ComplexesSec8l1 protein, mouseVesicular Transport Proteinsexocyst complexLRRK2Parkinson’s diseaseSec8

Identifiers

PMID33498474
PMCPMC7909581
OpenAlexW3123896609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.